MEG
DGX icon

Millstone Evans Group’s Quest Diagnostics DGX Stock Holding History

Millstone Evans Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Hold
148
– – 0.02% 439
2026
Q1 		$29K Hold
148
– – 0.02% 428
2025
Q4 		$25.7K Hold
148
– – 0.02% 436
2025
Q3 		$28.2K Hold
148
– – 0.02% 411
2025
Q2 		$26.6K Hold
148
– – 0.02% 409
2025
Q1 		$25K Hold
148
– – 0.02% 420
2024
Q4 		$22.3K Buy
+148
New +$23K 0.02% 401

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Millstone Evans Group's DGX Position: Q2 2026 in Review

Millstone Evans Group held its Quest Diagnostics (DGX) position steady in Q2 2026 at 148 shares worth $31.4K. The position accounts for 0.02% of the portfolio, ranked #439.

Millstone Evans Group first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 903 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Millstone Evans Group held 148 shares of Quest Diagnostics worth $31.4K as of Q2 2026.
  • Millstone Evans Group left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.02% of Millstone Evans Group's portfolio in Q2 2026, its #439 holding.
  • Millstone Evans Group first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 903 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.